Aspergillosis News and Research

RSS

Scientists develop a promising way to create new antifungal drug candidates

Scientists at Imperial College London and The University of Manchester have developed a promising new way to create safer and more effective treatments for life-threatening fungal infections.

29 Jul 2026

New antimicrobials could help tackle deadly drug-resistant infections

Scientists at Imperial College London and The University of Manchester have developed a promising new way to create safer and more effective treatments for life-threatening fungal infections.

29 Jul 2026

Blocking immune brake protein boosts defense against Aspergillus fumigatus

People are exposed to millions of fungal spores every day, even potentially harmful ones like those from Aspergillus fumigatus.

11 Sep 2025

Discovery of hybrid Aspergillus species with antifungal resistance in Japan

Aspergillus is a fungus that is commonly found in the environment, both indoors and outdoors. This fungus species can cause aspergillosis-a respiratory infection affecting the lungs. A. fumigatus, A. nidulans, and A. niger are some of the common species within the Aspergillus genus that cause aspergillosis.

17 Jul 2025

Climate models predict spread of deadly Aspergillus pathogens

Climate change is projected to shift the global distribution of key Aspergillus species, with northward movement of suitable habitats and changing risks for human health and agriculture. Advanced modelling reveals significant implications for food security and clinical fungal infections.

26 May 2025

Your home is full of mold, but daycares are teeming with yeast—here’s why

Researchers found that daycares have a higher abundance of yeasts, while private houses contain more spore-producing molds, with occupant density and ventilation playing key roles in fungal distribution.

23 Feb 2025

Key risk factors influencing mortality rates in chronic pulmonary aspergillosis patients

A systematic review reveals chronic pulmonary aspergillosis mortality is driven by age and underlying conditions, highlighting the need for targeted therapies.

3 Dec 2024

Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients

Study reveals 0.4%-2.7% incidence of COVID-19-associated pulmonary aspergillosis in severe patients, highlighting significant mortality risks and risk factors.

24 Sep 2024

Researchers analyze incidence of COVID-19-associated pulmonary aspergillosis in Japan

As society learns to live with COVID-19, research on the disease and its complications remains important.

20 Sep 2024

Promising new strategy to combat fungal infections

A group of Brazilian researchers has found a potential target for novel therapeutic strategies to combat fungal infections – more specifically, those caused by Aspergillus fumigatus. An article reporting the discovery is published in the journal Communications Biology.

5 Sep 2024

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

7 Dec 2023

Fighting invisible foes: How cryptic fungal pathogens threaten human health and food security

The research paper in PLOS Pathogens delves into the challenges of diagnosing and treating cryptic fungal pathogens, which are difficult to distinguish from common fungi but equally dangerous. The study calls for more accurate diagnostic methods and a better understanding of how these fungi interact with the human immune system and microbiome for effective treatment and prevention.

25 Oct 2023

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

The color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy.

11 Sep 2023

Understanding the mechanisms behind rising antifungal drug resistance

In a recent study, researchers addressed the issue of the rise of antifungal drugs-resistant infections and the advent of multidrug-resistant fungal pathogens.

19 Jul 2023

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

10 Jul 2023

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

Researchers identified a genetic association signal, via genome-wide association studies, between severe COVID-19 with systemic lupus erythematosus, an autoimmune disease.

7 Nov 2022

Aspergillosis News and Research

Scientists develop a promising way to create new antifungal drug candidates

New antimicrobials could help tackle deadly drug-resistant infections

Blocking immune brake protein boosts defense against Aspergillus fumigatus

Discovery of hybrid Aspergillus species with antifungal resistance in Japan

Climate models predict spread of deadly Aspergillus pathogens

Your home is full of mold, but daycares are teeming with yeast—here’s why

Key risk factors influencing mortality rates in chronic pulmonary aspergillosis patients

Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients

Researchers analyze incidence of COVID-19-associated pulmonary aspergillosis in Japan

Promising new strategy to combat fungal infections

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Fighting invisible foes: How cryptic fungal pathogens threaten human health and food security

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

Understanding the mechanisms behind rising antifungal drug resistance

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Analyzing impact of phospholipase D on the host immune response to A. fumigatus infection

How antiviral host responses create a lung environment susceptible to bacterial and fungal infections

New insights into deadly fungal invasion in people with compromised immune systems

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News